Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-122 with Methotrexate in Active Rheumatoid Arthritis
NCT02141997Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Bispecific Antibodies
01
Overview
A Phase 2 trial of remtolumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Jul 2014; status: completed.
02
Drugs
remtolumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02141997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141997.